Join us for a live, interactive TheraTalk session with an expert panel of nationally recognized lipid specialists as they review the latest guideline recommendations, pivotal evidence, and evolving strategies for LDL-C management.
Join us for a live webinar designed to support oncology clinicians in navigating the evolving treatment landscape of extensive-stage small cell lung cancer (ES-SCLC).
From recent surveys and CAR T clinical connection sessions, expert faculty will present the latest evidence and guideline recommendations to ensure your patients receive timely, potentially life-changing treatment.
Join us for a live webinar designed to support oncology clinicians in navigating the evolving treatment landscape of advanced non-small cell lung cancer (NSCLC).
Current evidence-based recommendations for prescribing diabetes medications, including newer pharmacologic classes such as glucagon-like peptide-1 receptor agonists (GLP-1r) and sodium glucose co-transporter-2 inhibitors (SGLTi) medications.
Close the technology gap and improve patient outcomes , this program provides a review of the latest diabetes technologies, including continuous glucose monitors (CGMs), insulin pumps, automated insulin delivery (AID) systems, and smart insulin pens.
$2395 includes 2 years Online Access + Live Hands-On with 2 Certificates (code NN202 at checkout) ✅Taught by Two Aesthetic MD's who oversee NP's ✅Max. 4 Providers per class ✅20u BTX and 1cc Filler included ⭐2025 aesthetic-training.com Top Pick
$2095 includes 2 years Online Access + Live Hands-On with 2 Certificates (use NN202 at checkout) ✅Taught by Aesthetic MD who oversees NP's ✅Max. 4 Providers per class ✅Hands-On Microneedling and Real Spun PRP ⭐2025 aesthetic-training.com Top Pick
Topics: MASH, PBS, IBD, IBS
Credits Offered: This event offers 1.5 CME credits to attendees
Target Audience: This activity has been designed to meet the educational needs of gastroenterology and hepatology APPs .
This dynamic, expert-led live webinar is designed to help you navigate the treatment landscape for advanced gastric and gastroesophageal junction (G/GEJ) adenocarcinomas.
